UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

 

June 21, 2018

 

 

 

TEARLAB CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   000-51030   59-343-4771

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

9980 Huennekens St., Ste 100

San Diego, CA 92121

(Address of principal executive offices, including zip code)

 

(858) 455-6006

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

We held our 2018 annual meeting of stockholders on June 21, 2018 (the “Annual Meeting”). Of the 10,438,998 shares of our common stock outstanding as the record date of April 27, 2018, 7,141,813 shares were represented at the Annual Meeting, either in person or by proxy, constituting approximately 68.42% of the outstanding shares of common stock. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below:

 

1. Election of Directors. Each of the following nominees was elected to serve as a director, to hold office until our 2019 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified based on the following results of voting:

 

Nominee  Votes For  Votes Withheld  Broker Non-Votes 
Elias Vamvakas  2,106,872  98,710  4,936,231 
Joseph Jensen  2,150,049  55,533  4,936,231 
Anthony E. Altig  2,159,080  46,502  4,936,231 
Paul M. Karpecki  2,125,008  80,574  4,936,231 
Richard L. Lindstrom  2,155,738  49,844  4,936,231 

 

2. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2018 was ratified based on the following results of voting:

 

For  Against   Abstentions 
6,662,616   469,760    9,437 

 

3. Advisory Vote on Approval of Executive Compensation. On an advisory (non-binding) basis, the stockholders approved the compensation of our named executive officers for the year ended December 31, 2017 as disclosed in our proxy statement:

 

For  Against   Abstentions   Broker Non-Votes 
1,921,281   256,362    27,939    4,936,231 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TEARLAB CORPORATION
     
  By: /s/ Michael Marquez
 

Michael Marquez

Interim Chief Financial Officer

 

Date: June 22, 2018